Schizophrenia :: Safety analyses of clinical data for bifeprunox in patients with schizophrenia
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.